Similar articles for PMID: 33722920

Year	Number of Results
1867	1
1868	1
1980	1
1983	1
1985	2
1986	1
1987	2
1989	1
1993	1
1994	1
1995	2
1996	2
1997	3
1998	3
1999	2
2000	5
2001	6
2002	8
2003	5
2004	4
2005	5
2006	5
2007	4
2008	2
2009	4
2010	6
2011	3
2012	2
2013	3
2014	2
2015	2
2016	1
2017	3
2018	2
2019	3
2020	4
2021	3

1

Antiseptic-Mediated Colloid Labeling as a Potential Source of Abnormal Liver and Spleen Uptake with ^99mTc-Dimercaptosuccinic Acid.

Krull V, Kocher MR, Rieter WJ. Krull V, et al. J Nucl Med Technol. 2021 Sep;49(3):290-291. doi: 10.2967/jnmt.120.258020. Epub 2021 Mar 15. J Nucl Med Technol. 2021. PMID: 33722920

2

The Effect of Antiseptic on 99mTc-DMSA Scans.

Firuzyar T, Ghaedian T. Firuzyar T, et al. Clin Nucl Med. 2017 Mar;42(3):237-238. doi: 10.1097/RLU.0000000000001531. Clin Nucl Med. 2017. PMID: 28072624

3

Alteration of the organ uptake of the (99m)Tc-radiopharmaceuticals, (99m)Tc-DPD, (99m)Tc-DMSA, (99m)Tc-tin colloid and (99m)Tc-MAA, induced by the applied cytotoxic drugs methotrexate sodium and cyclophosphamide.

Janković DLj, Djokić DDj. Janković DLj, et al. Nucl Med Commun. 2005 May;26(5):415-9. doi: 10.1097/00006231-200505000-00004. Nucl Med Commun. 2005. PMID: 15838423

4

Technetium Tc 99m Dimercaptosuccinic Acid.

[No authors listed] [No authors listed] 2021 Mar 17. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Mar 17. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000628 Free Books & Documents. Review.

5

Preparation and evaluation of (99m)Tc-DMSA lyophilized kit for renal imaging.

Jan SU, Abbass HG. Jan SU, et al. Pak J Pharm Sci. 2013 May;26(3):547-51. Pak J Pharm Sci. 2013. PMID: 23625428

6

Pentavalent Tc-99m dimercaptosuccinic acid imaging of hepatocellular carcinoma.

Wang SJ, Lin WY, Wey SP, Shen LH, Ting G. Wang SJ, et al. Neoplasma. 1999;46(4):246-8. Neoplasma. 1999. PMID: 10613606

7

Evaluation of stannous oxidation in the preparation of ultrahigh-purity 99m Tc(V)-DMSA.

Kumar V. Kumar V. Nucl Med Commun. 2001 Nov;22(11):1261-6. doi: 10.1097/00006231-200111000-00015. Nucl Med Commun. 2001. PMID: 11606894

8

Increased bone marrow uptake on Tc-99m DMSA scintigraphy in a patient with renal osteodystrophy.

Caglar M, Naldöken S. Caglar M, et al. Ann Nucl Med. 1993 Nov;7(4):281-3. doi: 10.1007/BF03164712. Ann Nucl Med. 1993. PMID: 8292457

9

A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.

Ohta H, Ishii M, Yoshizumi M, Endo K, Sakahara H, Nakajima T, Yomoda I, Masuda H, Horiuchi K, Hata N, et al. Ohta H, et al. Clin Nucl Med. 1985 Mar;10(3):167-70. doi: 10.1097/00003072-198503000-00006. Clin Nucl Med. 1985. PMID: 2985320

10

Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines.

Denoyer D, Perek N, Le Jeune N, Frere D, Dubois F. Denoyer D, et al. Eur J Nucl Med Mol Imaging. 2004 Jan;31(1):77-84. doi: 10.1007/s00259-003-1334-7. Epub 2003 Oct 14. Eur J Nucl Med Mol Imaging. 2004. PMID: 14557898

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed